Physician profile
Johan E Samanta
NPI 1487653739
$146,043.11
in general payments reported to CMS, 2019-2025
49 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $28K · 2021: $27K · 2022: $34K · 2023: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $3,874 · Travel and Lodging: $1,910 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,855 · Education: $6.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,647.50 |
| Food and Beverage | $3,873.85 |
| Travel and Lodging | $1,909.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,855.00 |
| Education | $6.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $74,289.71 | 2019-2023 | Ingrezza, Ongentys |
| Acorda Therapeutics, INC | $45,232.67 | 2019-2023 | Inbrija |
| Teva Pharmaceuticals USA, INC. | $4,413.16 | 2019-2023 | Austedo Xr, Austedo |
| Sunovion Pharmaceuticals INC. | $3,796.07 | 2020-2022 | |
| Abbvie INC. | $3,521.06 | 2019-2023 | Botox, Duopa, Qulipta |
| Acadia Pharmaceuticals INC | $1,811.73 | 2019-2023 | Nuplazid |
| Jazz Pharmaceuticals INC. | $1,653.19 | 2022 | |
| Medtronic, INC. | $1,540.78 | 2021-2022 | |
| Mdd US Operations, LLC | $1,200.75 | 2020-2023 | Apokyn, Xadago |
| Amneal Pharmaceuticals LLC | $1,135.25 | 2019-2023 | Rytary |
| Medtronic USA, INC. | $1,082.57 | 2019-2020 | |
| Allergan, INC. | $780.14 | 2019-2022 | |
| Abbott Laboratories | $698.34 | 2019-2023 | Infinity |
| Ucb, INC. | $631.71 | 2019-2021 | |
| Boston Scientific Corporation | $563.80 | 2019-2023 |
Show all 47 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johan Samanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.